The global automated external defibrillator market is forecasted to reach USD 3.1 billion in 2026 and expand to USD 4.8 billion by 2036, advancing at a CAGR of 4.5%. As per FMI, this outlook reflects a structural shift in emergency cardiac care, where sudden cardiac arrest response is moving from hospital-dependent treatment toward community-based intervention.
Automated external defibrillators are becoming part of public infrastructure across the globe. In the UK, there are more than 30,000 out of hospital cardiac arrests each year, survival is under 1 in 10, and a defibrillator is used in fewer than 10% of cases. That gap has turned AED deployment from a medical nice to have into an operational decision for airports, rail networks, schools, warehouses, and large venues. Different regions are solving the same minutes problem in different ways.
The UK is wiring AED location data into emergency response through The Circuit, designed as a live national database that links with ambulance service dispatch systems. The US leans on liability protection to unlock scale, with federal Good Samaritan protections written into the Cardiac Arrest Survival Act framework. After Damar Hamlin’s on field cardiac arrest in January 2023, the American Heart Association reported a more than 600% surge in views of hands only CPR resources, a signal that public readiness can spike overnight.
Product roadmaps favor longer life pads and batteries, simpler pediatric switching, self tests, and connectivity that can flag expired consumables without a site visit. Fleet software is bundled to track readiness logs, recall notices, and replacement cycles across AED networks. Supply chain has also become strategic. MedTech Europe has warned that the semiconductor shortage is disrupting production of medical technologies, forcing redesigns, dual sourcing, and inventory buffering to protect deliveries.
Manufacturers now sell readiness, not just hardware. Regulatory load is rising across regions, with USA PMA oversight and EU MDR conformity expectations pushing deeper documentation and post market surveillance. Product roadmaps favor longer life pads and batteries, simpler pediatric switching, self tests, and connectivity that can flag expired consumables without a site visit. Fleet software is bundled to track readiness logs, recall notices, and replacement cycles across AED networks. Supply chain has also become strategic. MedTech Europe has warned that the semiconductor shortage is disrupting production of medical technologies, forcing redesigns, dual sourcing, and inventory buffering to protect deliveries.
“As we think about trade policy and supply chains, it’s essential that this industry is protected for humanitarian reasons, as it historically has been.” ~ AdvaMed CEO Scott Whitaker
| Metric | Value |
|---|---|
| Market Value (2026) | USD 3.1 billion |
| Market Forecast Value (2036) | USD 4.8 billion |
| Forecast CAGR (2026-2036) | 4.5% |
From 2026 and beyond, the automated external defibrillator market will be more influenced by regulated systems and operational readiness. The FDA's 2015 final order pushed AED systems into a premarket approval pathway after repeated reliability problems, which means design changes and component substitutions are no longer routine engineering decisions but submission and evidence problems. Smaller brands will struggle with documentation depth and lifecycle traceability while larger players treat compliance as a competitive advantage.
At the same time, buyers are realizing that an AED on a wall is not the same as an AED that is ready at the moment of shock. UK policy addresses this through The Circuit, a national location and availability mapping system that lets emergency call handlers direct bystanders to the nearest registered device. That operational logic pulls manufacturers into fleet management features like remote status monitoring, expiry alerts for pads and batteries, self-test logs, and recall notification workflows.
In the US, AED adoption is moving from local champions to system design by 911 and public safety agencies. PulsePoint's Emergency AED Registry integrates with major emergency medical dispatch and mapping vendors so telecommunicators can surface exact AED locations inside their dispatch workflows. The winning device is the one that can be registered, verified, maintained, and surfaced inside CAD workflows at scale, which reshapes channel strategy and makes relationships with EMS software ecosystems matter as much as distributor coverage.
The next decade will widen AED access through community responder activation and aerial delivery. GoodSAM integrates with ambulance CAD systems to trigger nearby trained responders while the ambulance is en route. Drone delivery is moving beyond headlines into measured operational learning, with NHS-led studies in Wales reporting concrete timings from emergency call to drone takeoff and peer-reviewed work documenting real deployments in Sweden. For manufacturers, this creates new requirements: ruggedization for drop and weather, clearer audio guidance in noisy outdoor scenes, faster boot and analysis cycles, and packaging optimized for drone payload constraints.
Connectivity is becoming central to readiness programs, but it drags cybersecurity into the core of product design. The FDA refreshed its cybersecurity recommendations in 2025 for what needs to be built into design controls and premarket submissions, while Europe's MDCG guidance frames cybersecurity expectations under MDR as spanning both pre-market and post-market obligations. Secure update mechanisms, vulnerability disclosure and response, software bill of materials discipline, and ongoing monitoring become part of the cost of selling connected AED fleets. Buyers will start asking for proof of update policy, end-of-support timelines, and incident response commitments, especially in public sector tenders.
Procurement and supply chain are becoming strategic issues as two real-world forces collide. Semiconductor fragility has been flagged by MedTech Europe as a supply risk that pressures manufacturing continuity, while procurement is getting more political. The EU has used its International Procurement Instrument to restrict participation of Chinese firms in large medical device tenders, and a recent Airports Authority of India tender explicitly references Make in India procurement rules and local supplier classification.
The combined effect from 2026 to 2036 is predictable: more dual sourcing, more redesigns to substitute constrained components, more local assembly partnerships, and a stronger push toward standardized platforms that can be certified and produced across multiple regions without rework. Demand growth will increasingly come from policy-led installation waves that create bulk procurement and recurring service cycles.
The automated external defibrillator market is segmented by product type into semi-automated AED and fully automated AED, by end-user into public access, healthcare facilities, and home care, by application into hospitals, public access facilities, schools, airports, sports facilities, and others, and by region into Asia Pacific, Europe, North America, Latin America, and Middle East and Africa.
Semi-automated AEDs continue to enjoy higher demand as the device decides if a shock is needed, the responder decides when to deliver it. That extra human step reduces accidental shocks during messy, real world rescues where people are moving, compressions are ongoing, and scene control matters. It also fits how workplaces and community programs are built, with nominated first aiders trained to follow prompts and coordinate safety. Public deployment is accelerating through mandated placement and formal response plans. In the UK, The Circuit reached 100,000 registered defibrillators and government briefings note 59% are always accessible, signalling ongoing placement and readiness governance.
In the USA, new and updated school requirements pair AED access with trained response teams and drills, reinforcing semi automated preference in supervised public environments. Manufacturers keep this workflow central, with major lines offering semi automated variants that retain a shock button while adding remote readiness management. France keeps expanding public deployment through legal obligations on establishments receiving the public, reinforced by a December 2025 decree updating who must equip with an AED. That grows the installed base that is used by non-clinicians, where a supervised shock step fits duty of care. In Germany, public response systems are getting operationalised through AED registries and first responder apps.
Berlin examples include DefiNetz and Berlin Schockt, making AED locations usable in real dispatch flows, which favours semi-automated devices that assume a human responder is present and trained. Across Europe, the 2025 European Resuscitation Council guidance pushes public access AED deployment and highlights smartphone tools that locate AEDs and mobilise citizen responders. That is a scale model built around semi-automated workflows, not around fully automated shock delivery. Fully automated units fit professional environments that want fewer user steps, tighter protocol control, higher device standardisation. Semi-automated units fit mass deployment where training, safety discipline, accountability drive adoption.
Public access remains the largest end use as policy, infrastructure, and operating models push AEDs into high footfall places where first response sits with citizens, staff, security, or trained volunteers. The European Resuscitation Council 2025 systems guidance calls for first responder dispatch linked to AED registries, so the device becomes part of a mapped response network. France tightened this logic in late 2025 through a decree that updates which establishments receiving the public must equip with an AED, adding capacity and duration criteria that expand compliant placement across more venue types. Germany illustrates the same operating shift at city level. .
Berlin relies on registries run by DefiNetz and Berlin Schockt that are visible to volunteer responders through their apps, turning location data into dispatchable capacity. Japan demonstrates what maturity looks like when government policy normalises public access deployment, with research citing over 670,000 AEDs installed since 2004 across public places. India still shows uneven penetration, which keeps public access as the growth engine, illustrated by Delhi Metro reporting AEDs at only six stations on the Airport Express Line, leaving large coverage gaps across the wider network.
Healthcare facilities remain a large second pillar for a different reason. Hospitals buy AEDs as part of clinical governance, device standardisation, and code team protocols. Selection criteria shift toward integration with monitoring workflows, service contracts, battery and electrode logistics, and tighter training compliance. The buying centre sits with biomedical engineering plus clinical leadership, not with facilities managers. The product is evaluated as a component of a broader resuscitation system that includes crash carts, telemetry, and post event documentation. Public access spending scales by placement count and readiness discipline across many sites. Healthcare spending scales by standardisation across fewer sites with higher acuity requirements.
| Operational and Supply Chain Development | Company Tactics |
|---|---|
| Manufacturing automation and localization | Philips and ZOLL Medical Corporation completed the first automated AED production line in the US in December 2025, using a lean manufacturing approach. This automation shortens production timelines, reduces labor costs, and increases scalability, especially for North American markets. |
| Vessel efficiency and loading density | Defibtech began constructing the "AED Infinity" in September 2025, a mobile AED unit with a 2,500-unit capacity that can serve multiple public spaces simultaneously. Fewer transport trips per project, accelerating deployment across high-density urban areas, with an estimated 35% reduction in transportation costs. |
| Vertical integration through M&A | Physio-Control acquired HeartSine Technologies in January 2026 for $200 million, adding capabilities in compact AED systems and next-gen wireless communication features. This expands product offerings and strengthens R&D capabilities, allowing faster development of more user-friendly and connected AEDs. |
| Depth and precision engineering | Cardiac Science completed an advanced 360-degree monitoring system for AEDs in January 2026, integrating real-time ECG feedback and automated device diagnostics. This enhances treatment efficacy and reliability, especially for use in critical care and remote areas, with a focus on user safety and system precision. |
Source: FMI’s proprietary forecasting model and primary research
Global demand for AED solutions is increasing as organizations expand emergency response infrastructure while addressing regulatory compliance, liability protection, and public safety application requirements. Growth reflects rising use of connected devices, automated monitoring systems, and training-integrated platforms across public facilities, workplace environments, and community response networks. Device selection focuses on reliability properties, training efficiency, and cost performance under various deployment scenarios. India records 7.2% CAGR, USA records 5.1% CAGR, Germany records 4.8% CAGR, Japan records 4.2% CAGR, and UK records 3.9% CAGR. Adoption remains driven by regulatory requirements and liability considerations rather than technology advancement alone.
| Country | CAGR (2026-2036) |
|---|---|
| India | 7.2% |
| USA | 5.1% |
| Germany | 4.8% |
| Japan | 4.2% |
| UK | 3.9% |
India’s AED landscape is shifting from episodic device placement to capability building at scale, with training as the lead indicator and procurement following. In the last two to three years, the Ministry of Health and Family Welfare has pushed mass hands only CPR awareness, reporting CPR training for over 6.06 lakh participants during the October 2025 CPR Awareness Week.
In parallel, workplace safety institutions have formalised first aid and CPR training for employees through Central Labour Institute programs under the Ministry of Labour ecosystem, which expands the pool of trained responders in factories, ports, and large worksites. This creates a predictable operating model for public access defibrillation: trained non clinicians, clear escalation protocols, and recurring refresher cycles.
Deployment is still uneven across public infrastructure, which keeps growth anchored in catch up rather than replacement. Metro coverage remains limited in high footfall networks, while transport hubs are moving through structured government procurement, visible in repeated Airports Authority of India tenders for supply, installation, testing, and commissioning of AEDs via GeM.
Over the next five years, expect acceleration through three moves: AED placement tied to safety compliance in airports, large employers, and campuses; training embedded earlier in the pipeline through school and college CPR programs proposed by clinical leaders; and gradual build out of registries and response choreography so devices become dispatchable assets, not passive hardware. The Indian AED market is set to grow at a 7.2% CAGR during the study period, led by massive demand in the government and public facility sectors.
The US AED landscape is tightening around system reliability and measurable response performance. FDA oversight now expects AED makers to operate under the premarket approval pathway, with approval required before many device or labeling changes, plus ongoing reporting and post market monitoring. That regulatory posture is colliding with the reality that out of hospital cardiac arrest volume is large and trackable. CARES reported 137,119 non traumatic EMS treated OHCAs in 2024 and, as of January 2025, covered about 56 percent of the US population, with 2,600 plus EMS agencies and 2,200 plus hospitals participating. This is shifting the buying conversation from unit price to readiness, maintenance compliance, data visibility, and time to shock.
Over the next five years, growth is likely to come from mandated placement plus program governance rather than from pure device innovation. CDC mapping of public access defibrillation laws shows broad state level action on AED placement expectations, which keeps schools, sports venues, and public gathering sites in the procurement funnel. Federal attention is also moving toward transport infrastructure, visible in proposed legislation focused on AED access at interstate transportation facilities. Clinical direction reinforces the same operating model, with the 2025 AHA guidance emphasizing systems of care where early defibrillation is paired with dispatch and community response. For manufacturers, the playbook shifts toward connected fleet management, service revenue, and cybersecurity grade documentation aligned with FDA expectations for connected medical devices.
Germany’s AED landscape is moving from static placement toward dispatchable coverage, built on two reinforcing system upgrades. First, national and local actors are making AED locations machine readable and usable in real response flows. A Berlin study shows two nonprofit registries, DefiNetz and Berlin Schockt, that are accessible to volunteer first responders, which links mapping, alerting, and retrieval into one operational chain. Second, Germany is scaling smartphone based first responder alerting at program level. The HEROES trial is evaluating a geo referenced alerting system across multiple regions, testing whether systematic dispatch of nearby responders improves survival outcomes.
For manufacturers and procurement leaders, the next five years tilt toward governance, traceability, and uptime economics rather than pure feature competition. The German Resuscitation Council has translated and operationalised the 2025 ERC guidance, pushing consistency in basic life support and early defibrillation training, which increases demand for standardised fleets and refresher cycles. On the regulatory side, Germany’s device administration is preparing for the shift to mandatory EUDAMED registration from 28 May 2026 with a transition period, raising the bar on UDI discipline, documentation quality, and post market processes for AED suppliers. The net effect is a market that rewards vendors who can plug into registries, support alerting workflows, and prove readiness at fleet level.
Japan’s AED landscape is mature on placement and still underpenetrated on use. Government guidance has treated AED deployment and management as a public responsibility for years, anchored in national placement and accessibility guidance under the health ministry. The performance constraint now sits in the last mile of response. The All Japan Utstein Registry publication in 2024 reports bystander use of public access AEDs at about 1.3 percent across included cases, despite high national availability. The same period shows how fragile public access defibrillation can be when mobility patterns change, with pandemic era analyses linking reduced public movement to shifts in public access defibrillation incidence and outcomes.
The next five years are likely to be defined by converting an installed base into a dispatchable capability. That means tighter mapping, faster retrieval, and higher probability of shock delivery before EMS arrival, especially outside transport hubs and commercial venues. Two visible signals sit in the consumer layer. Japan has active AED location map apps updated in 2025 that operationalise finding a nearby device during an event rather than relying on signage memory. On the system layer, current research is testing what universal early bystander AED access could deliver at population level, reinforcing a policy direction toward earlier shock and broader citizen activation. For medtech executives, the strategic axis is readiness management plus integration with registries and responder workflows, not incremental hardware features.
The UK AED landscape is consolidating around one national operating system rather than fragmented local placement. The Circuit links registered devices to all UK ambulance services, so a 999 call handler can direct a bystander to a known location with known access arrangements. That system has scaled fast. The House of Commons Library notes there is no general legal requirement to provide public access defibrillators, yet voluntary deployment keeps rising and policy attention has shifted to readiness, registration, and accessibility. Schools have become a major anchor point. The Department for Education guidance asks schools to register devices on The Circuit, and Parliament records that the England schools programme has provided over 20,000 devices.
The next five years look like a governance upgrade. Coverage is no longer the only constraint. Access hours, maintenance discipline, and location quality drive clinical value. Parliament reports that only 59 percent of registered devices are always accessible, which becomes the next performance frontier for employers, councils, and venue operators. Deployment strategy is also becoming more data led. NIHR funded work in 2025 describes optimisation methods to decide where public access AEDs should sit based on need and response dynamics. Expect procurement to reward manufacturers that support fleet readiness checks, guardian workflows, and registry integration that keeps each device dispatchable rather than merely installed.]
The global AED category is consolidating around a small group of leaders. ZOLL Medical, Stryker, Nihon Kohden, and Philips Emergency Care sit in this tier because they cover both public access and professional response use cases, sustain multiple product families, and support large multi site deployments where readiness discipline and lifecycle support drive buying decisions.
ZOLL’s positioning is built on breadth across public access and clinical response, reinforced by the parallel ZOLL and Powerheart families. That dual family posture fits buyers who manage mixed environments across workplaces, public venues, and institutional settings. The strategic signal is continued lifecycle investment that keeps multiple platforms current and supportable.
Stryker’s leadership comes from scale across EMS and public access, with strong pull where customers standardise across professional and lay responder environments. The commercial posture leans toward deployments that need readiness discipline at fleet level. The strategic signal is portfolio simplification and platform consolidation that reduce complexity and improve standardisation for large buyers.
Nihon Kohden’s position is anchored in structural strength in Japan plus an established US platform through Defibtech, with momentum supported by shipment scale and sustained domestic demand pull. The portfolio is well suited to public access placements that value simplicity and durability. The strategic signal is Japan volume direction and road map continuity across domestic and export markets. Philips Emergency Care remains a leader through installed base strength and global franchise recognition, with the strategic watchpoint centered on ownership transition and its effect on R and D cadence, commercial focus, and service continuity.
Mid-tier players are focusing on gaining market share through regional strength and distributor anchored execution. SCHILLER holds a credible European footprint across lay responder to advanced use cases, with a narrower global program layer than the leaders. Mindray is scaling rapidly outside the US through broad distribution and modern portfolio design, with post market governance becoming more visible as footprint expands. Bexen Cardio is building EU focused momentum through regulatory progress and structured field communications, constrained by narrower distribution and fewer large scale fleet program deployments. Growing stage players such as Avive lean into connectivity first fleet management as the wedge, while CU Medical Systems competes through distributor networks in tender led markets. In practical terms, leaders win where CXOs need governability across hundreds or thousands of sites, mid-tier wins where procurement is regionally anchored, and growing stage wins where buyers accept switching risk to gain a modern service model.
Key Players in the Automated External Defibrillator Market
The automated external defibrillator market represents revenues generated from the manufacture and sale of automated external defibrillators used to deliver an electric shock to restore a viable heart rhythm during sudden cardiac arrest. The market covers semi-automated and fully automated AED devices deployed across public access locations, healthcare facilities, and home care settings, and is analyzed across the 2026 to 2036 period. Market sizing is revenue-based in USD and reflects device sales into end-use environments such as airports, schools, workplaces, hospitals, and other public facilities where early defibrillation is part of an emergency response pathway.
| Items | Values |
|---|---|
| Quantitative Units | USD billion |
| Product Type | Semi-automated AED; Fully Automated AED |
| End-User | Public Access; Healthcare Facilities; Home Care |
| Application | Hospitals; Public Access Facilities; Schools; Airports; Sports Facilities; Others |
| Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East & Africa |
| Countries Covered | India, USA, Germany, Japan, UK, and 40+ countries |
| Key Companies Profiled | Philips Healthcare; Zoll Medical Corporation; Physio-Control Inc.; Cardiac Science Corporation; Defibtech LLC; Others |
| Additional Attributes | Dollar sales by product type, end-user, and application; performance in emergency response and device reliability across public access platforms, healthcare facilities, and workplace environments; device quality improvement, training efficiency enhancement, and response benefit under emergency situations; impact on survival rates, response coordination, and cost management during emergency processes; compatibility with emergency response systems and safety requirements; procurement dynamics driven by regulatory compliance, liability considerations, and long-term AED deployment partnerships. |
How big is the automated external defibrillator market in 2026?How big is How big is the automated external defibrillator market in 2026?the automated external defibrillator market in 2026?
The global automated external defibrillator market is estimated to be valued at USD 3.1 billion in 2026.
What will be the size of the automated external defibrillator market in 2036?
The market size for the automated external defibrillator market is projected to reach USD 4.8 billion by 2036.
How much will the automated external defibrillator market grow between 2026 and 2036?
The automated external defibrillator market is expected to grow at a 4.5% CAGR between 2026 and 2036.
What are the key product types in the automated external defibrillator market?
The key product types in the automated external defibrillator market include semi-automated AED devices and fully automated AED platforms.
Which end-user segment will contribute a significant share in the automated external defibrillator market in 2026?
In terms of end-user category, the public access segment is set to command a 54.2% share in the automated external defibrillator market in 2026.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Automated External Defibrillator Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
